ASCO 2014: Assessing Prostate Cancer Incidence Rates
The Particulars: It has been hypothesized that greater use of prostate specific antigen (PSA)...
Read More
Prostate Cancer
ASCO 2014: Perceptions on Novel Prostate Cancer Technology
The Particulars: The use of robotic surgery and proton beam therapy for the treatment of prostate...
Read More
ASCO 2014: Improving Prostate Cancer Screening
The Particulars: Measuring prostate-specific antigen (PSA) has been shown to be an effective way...
Read More
AUA 2014: Comparing the Efficacy of Prostatectomy Approaches
The Particulars: Prior studies have not definitively shown that robotic-assisted radical...
Read More
Radiation Therapy After Prostatectomy
Radical prostatectomy (RP) is the most common primary treatment for localized prostate cancer. For...
Read More
PSA Screening: More Harm Than Good
A new analysis presented at the European Cancer Conference 2013 adds fuel to the ongoing debate...
Read More
Functional Outcomes After Treatment for Prostate Cancer
Studies have shown that patients with localized prostate cancer have favorable long-term overall...
Read More
Men’s Fitness in Middle Age Protects Against Cancer
Findings from a large, prospective 20-year study indicate that a high level of cardiovascular...
Read More
AUA 2013: New Guideline on Radiation Therapy After Prostatectomy
San Diego, May 7, 2013 – The American Society for Radiation Oncology (ASTRO) and the American...
Read More
AUA 2013: Metabolic Syndrome Predicts Complications in Genitourinary Oncologic Surgery
The Particulars: Metabolic syndrome has been shown in previous studies to be predictive of...
Read More
AUA 2013: No Cost-Effective Way to Save Lives from Prostate Cancer
SAN DIEGO — All of the current treatment strategies for castration-resistant prostate cancer...
Read More
AUA 2013: Prostate Cancer Surgery May Relieve LUTS
SAN DIEGO — Radical prostatectomy may offer the added benefit of urinary symptom reduction in...
Read More
AUA Issues New Guidelines on PSA Screening
New guidelines on prostate cancer screening, issued today by the American Urological Association...
Read More
Discontinuing PSA Screening: Perspectives From PCPs
Age and life expectancy appear to be considered often by primary care providers (PCPs) when...
Read More
FDA Expands Zytiga’s Use for Late-stage Prostate Cancer
Drug can now be used before treatment with chemotherapy The U.S. Food and Drug Administration...
Read More
Anesthesiology 2012: Study Finds Link Between Robotic Prostate Surgery and Increased Eye Injury Over 10-Year Period
A study presented at the Anesthesiology 2012 annual meeting found that during the years 2000-2009,...
Read More
Decision-Making Patterns in Prostate Cancer
University of North Carolina researchers have found that decision-making patterns appear to vary...
Read More
FDA Approves Production of Imaging Agent that Helps Detect Prostate Cancer
The U.S. Food and Drug Administration today approved the production and use of Choline C 11...
Read More
FDA Approves Enzalutamide for a Type of Late-Stage Prostate Cancer
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with...
Read More
Trends in IMRT for Prostate Cancer
A University of Michigan study has found that intensity-modulated radiotherapy (IMRT) appears to...
Read More